Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date Sort descending | Activity Code(s) | Title |
---|---|---|---|
PAR-21-115 | January 8, 2025 | R01 | Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
PA-21-201 | January 8, 2025 | R01 | Research on Autism Spectrum Disorders (R01 Clinical Trial Optional) |
PAR-21-357 | January 8, 2025 | R15 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) |
PAR-22-060 | January 8, 2025 | R15 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
NOT-HL-22-025 | January 8, 2025 | R01 | Notice of Special Interest (NOSI): Respiratory Complications of the Muscular Dystrophies (R01) |
NOT-HD-22-038 | January 8, 2025 | R15,R03,R01,R21 | Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NICHD Populations of Interest |
PAR-21-305 | January 10, 2025 | R01 | Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
NOT-DK-24-014 | January 10, 2025 | Notice of Change to Extend Application Due Dates for PAR-21-305 - Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) | |
PAR-23-114 | January 18, 2025 | R25 | Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed) |
RFA-MH-25-100 | January 18, 2025 | U01 | BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed) |
RFA-NS-24-021 | February 7, 2025 | R01 | HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) |
RFA-NS-24-014 | February 11, 2025 | R25 | NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed) |
NOT-AI-23-009 | February 14, 2025 | 333 | Notice of Special Interest (NOSI): Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem |
NOT-OD-24-044 | February 14, 2025 | R21 | Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed) |
RFA-NS-22-022 | March 12, 2025 | K99/R00 | HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed) |
RFA-NS-22-023 | March 12, 2025 | K99/R00 | HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required) |
RFA-NS-22-024 | March 12, 2025 | K99/R00 | HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required) |
RFA-NS-22-025 | March 12, 2025 | K99/R00 | HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) |
NOT-HD-22-049 | March 16, 2025 | R01,R03,R21 | "Notice of Special Interest (NOSI): High Priority Areas in Placental Research for Healthy Pregnancies" (Reissue) |
NOT-OD-22-142 | March 17, 2025 | R21 | Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional) |